American International Group (AIG) has long been a phoenix in the insurance world, rising from the ashes of the 2008 financial crisis when it required a staggering $182 billion government bailout—the largest in U.S. history—to repay it all by 2013 with a tidy profit for taxpayers. Fast forward through a decade of deleveraging, divestitures, and leadership shakeups, including the 2021 appointment of Peter Zaffino as CEO to spearhead a “transformation,” and AIG today looks leaner and more focused. The Corebridge Financial spin-off in 2022 shed its legacy life and retirement business, allowing AIG to zero in on commercial, specialty, and reinsurance lines. With shares trading near recent lows for the year, the company’s fundamentals paint a picture of operational efficiency amid cyclical pressures, setting the stage for analysts’ optimistic projections. Let’s unpack the numbers and narratives driving this story.

Revenue Resilience and Efficiency Gains

AIG’s revenue tells a tale of peaks and strategic pruning. From a high of $52.2 billion in 2021—a 19% jump from 2020’s $43.7 billion, fueled by investment gains and premium growth amid pandemic market volatility—it plummeted to $27.3 billion by 2024, a 46% decline over three years. This wasn’t just market whims; it reflected the Corebridge exit and a deliberate shift away from volatile personal lines. Yet, look deeper: revenue per employee has soared, climbing from $929,000 in 2016 to $1.23 million in 2024—a 32% increase. Headcount slashed from 56,400 to 22,200 over the same stretch (a 61% cut) underscores ruthless cost discipline, a hallmark of Zaffino’s regime. This metric matters because in insurance, where fixed costs loom large, productivity per worker signals scalable profitability—think of it as the company’s “output per warrior” in a battle against claims inflation and catastrophes.

Analyst forecasts brighten the horizon: revenue is pegged to rebound to $27.7 billion in 2025 (2% growth), $29.5 billion in 2026 (6% YoY), and $31.3 billion in 2027 (6% again). Paired with flat-to-shrinking shares outstanding (down to 539 million from over 1 billion in 2016, via buybacks), this juices per-share metrics. Revenue per share, for instance, is expected to hit $58.24 in 2027, up 39% from 2024’s $41.83. If history rhymes, these upticks could mirror post-2020 recovery, when revenue surged on favorable rates and underwriting discipline.

Profitability Swings: From Losses to Projected Powerhouse

Earnings volatility is insurance’s middle name, but AIG’s arc is dramatic. Net income swung from a $5.8 billion loss in 2020 (pandemic claims bonanza) to $10.9 billion gain in 2021 (investment windfalls), peaking at $11.3 billion in 2022 before a $0.9 billion loss in 2023—largely from catastrophe losses and reserve strengthening. Earnings per share (EPS) mirrored this: -$6.88 in 2020 to $13.16 in 2022, then -$2.19 in 2023. Crucially, 2024 flipped to $3.63 billion profit ($6.03 EPS), with EBT margins rebounding to 14.2% from 10.3% in 2023.

Why care about EBT margin? It’s earnings before tax—a purer gauge of core operations in a tax-shielded industry like insurance, stripping policyholder dividends and investment quirks. Gross margins stabilized around 26% post-2021 (from teens earlier), reflecting better pricing power. ROE, a key return-on-equity measure for shareholder value, cratered to -8.9% in 2020 but hit 18.3% in 2022; projections don’t specify but imply strength via rising EPS.

Future outlook sparkles: analysts eye $3.6 billion net income in 2025 (285% YoY rebound), $4.3 billion in 2026 (17% growth), and $4.6 billion in 2027 (8%). EPS climbs to $7.26 (2026, +20%) and $8.58 (2027, +18%). Cash flow per share, volatile but positive lately at $5.02 in 2024 (vs. $8.68 in 2023), supports this via free cash flow of $3.3 billion in 2024—vital for buybacks and dividends in a capital-intensive sector.

Balance Sheet Fortification

Debt tells AIG’s redemption story best. Total debt plunged from $37.5 billion in 2020 to $8.9 billion in 2024—a 76% haircut—while net debt fell 78% to $7.6 billion. Shareholder equity dipped to $42.6 billion in 2024 from $68.9 billion in 2021 (38% drop, tied to buybacks and spin-off), but book value per share holds steady around $65-$72. PB ratios hover near 1x, reasonable for insurers promising steady returns.

Working capital remains negative (a norm for float-heavy insurers like Berkshire’s model), but shrinking from -$270 billion peaks. ROIC at 4.1% in 2024 (up from 3.0% prior) shows capital deployed wisely. EV/Sales drops to 2.7x in 2024 from 3.2x in 2022, with projections tightening to 1.3x by 2027—attractive if growth materializes. Correlations here are tight: debt cuts track employee reductions and revenue refocus, boosting margins and freeing cash for $7.2 billion FCF projected in 2025.

Stock Performance: Aligning with Fundamentals?

Historical prices (yearly lows/highs) reveal resilience. From 2016’s $48-$67 range, shares tested $16 lows in 2020’s panic before rallying to $37-$63 (2021) and $47-$66 (2022). By 2024, $66-$81 marked new highs, up ~25% from 2023’s $46-$68. Current levels sit about even with 2024 lows but below highs, implying a 20-30% discount to peaks amid broader market jitters.

Compare to multiples: PE was dirt-cheap at 4.9x in 2022 (on $13 EPS), ballooned post-losses, now ~13x trailing but projected to 10.8x (2026) and 9.1x (2027)—bargain territory if EPS delivers. PS ratios peaked at 1.8x in 2023 on depressed revenue, now 1.7x. Stock lagged revenue drops but outperformed earnings volatility, thanks to buybacks (shares -40% since 2020). Post-Corebridge, price correlates strongly with ROE recovery, up ~100% from 2020 lows as efficiency shone.

Insider Signals: Mixed Messages

Insider activity adds intrigue. One director scooped up modest stakes—11 shares in June 2025 (cost $900), 653 in August ($50k), 15 in September ($1.2k), 14 in December ($1.2k)—total cost ~$54k, signaling quiet confidence at dips. But May 2025 saw heavy selling: five execs (EVPs in ops, accounting, admin, GC, underwriting) offloaded ~137k shares for $11.9 million total. Routine? Likely—scheduled 10b5-1 plans post-earnings—but volume dwarfs buys 220x by value. No sells since, per data through Feb 2026. Watch for more buys as a bullish tell; exec sales feel like profit-taking in a transforming firm.

Outlook: Upside with Tailwinds

Analysts’ price targets whisper optimism: low end implies negligible downside (about flat), average suggests ~9% upside, high end ~29% potential. At projected 2027 revenue ($31.3B, +15% from 2024), EPS $8.58, and tightening multiples, this aligns. Tailwinds? Rising rates boost investment income (EBT to $7B in 2025?), benign cats post-2023, and Asia/General growth. Risks: claims inflation, geopolitics echoing 2008.

AIG’s narrative? A mid-career survivor streamlining for alpha. Fundamentals scream value—debt tamed, efficiency peaked, earnings poised. If Zaffino’s culture of accountability sticks, shares could reprise 2021’s surge. Buy the transformation story, but size for volatility. (Word count: 1,128)